Siegfried Holding AG is a Switzerland-based life sciences company and active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States and China.

Pharmaceutical

Siegfried Holding

Wolfgang Wienand

Peter Stierli

Henrik Krüpper

Irene Wosgien

Jürgen Roos

Reto Suter

Marianne Späne

Marcel Imwinkelried

The Leadership Team at Siegfried Holding is responsible for guiding the strategic direction and overall management of the company. This team collaborates across various domains—operations, finance, science, human resources, and business development—to drive innovation and efficiency in the manufacturing of drug substances and drug products. By leveraging their diverse expertise, they ensure the company meets its goals in delivering critical pharmaceutical solutions while maintaining compliance with industry standards and fostering a collaborative culture.

Leadership Team

Quality Assurance and Control

Analytical Development and Support

Leadership Team

About

Team members

Other teams at Siegfried Holding

Quality Assurance and Control

Analytical Development and Support